Found: 14
Select item for more details and to access through your institution.
Involvement of cytochrome P450 enzymes in inflammation and cancer: a review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The use of zebrafish model in prostate cancer therapeutic development and discovery.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Irinotecan-induced intestinal mucositis in mice: a histopathological study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8<sup>+</sup> T cell augmentation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 3, p. 437, doi. 10.1007/s00280-021-04234-0
- By:
- Publication type:
- Article
Acknowledgement of reviewers 2020.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 3, p. 443, doi. 10.1007/s00280-021-04231-3
- Publication type:
- Article